Concert Pharmaceutic (CNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 101,705 | -26,360 | -13,333 | -50,720 | -38,677 |
| Depreciation Amortization | 779 | 474 | 235 | 1,082 | 821 |
| Accounts receivable | 19 | -246 | 14 | 43 | 57 |
| Accounts payable and accrued liabilities | -64 | 455 | 983 | 44 | 954 |
| Other Working Capital | 803 | -869 | -1,692 | -774 | 177 |
| Other Operating Activity | 7,194 | 3,011 | 646 | 4,982 | 2,822 |
| Operating Cash Flow | $110,436 | $-23,535 | $-13,147 | $-45,343 | $-33,846 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -119,529 | -20,336 | -291 | -6,443 | -28,859 |
| PPE Investments | -653 | -229 | -150 | -770 | -295 |
| Investing Cash Flow | $-120,182 | $-20,565 | $-441 | $-7,213 | $-29,154 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 29,659 | 29,680 | N/A | N/A | N/A |
| Debt Repayment | -30,745 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 2,396 | 1,456 | 1,139 | N/A | 293 |
| Other Financing Activity | 0 | 0 | 0 | 601 | 0 |
| Financing Cash Flow | $1,310 | $31,136 | $1,139 | $601 | $293 |
| Beginning Cash Position | 40,955 | 40,955 | 40,955 | 92,910 | 92,510 |
| End Cash Position | 32,519 | 27,991 | 28,506 | 40,955 | 29,803 |
| Net Cash Flow | $-8,436 | $-12,964 | $-12,449 | $-51,955 | $-62,707 |
| Free Cash Flow | |||||
| Operating Cash Flow | 110,436 | -23,535 | -13,147 | -45,343 | -33,846 |
| Capital Expenditure | -653 | -229 | -150 | -770 | -295 |
| Free Cash Flow | 109,783 | -23,764 | -13,297 | -46,113 | -34,141 |